Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $80.9B |
| FY2017, ended Dec 31, 2017 | $73.6B |
| FY2018, ended Dec 31, 2018 | $85.0B |
| FY2019, ended Dec 31, 2019 | $96.9B |
| FY2020, ended Dec 31, 2020 | $89.6B |
| FY2021, ended Dec 31, 2021 | $135B |
| FY2022, ended Dec 31, 2022 | $120B |
| FY2023, ended Dec 31, 2023 | $99.4B |
| FY2024, ended Dec 31, 2024 | $56.6B |
| FY2025, ended Dec 31, 2025 | $101B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $132B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $178B |
| FY2017, ended Dec 31, 2017 | $185B |
| FY2018, ended Dec 31, 2018 | $195B |
| FY2019, ended Dec 31, 2019 | $257B |
| FY2020, ended Dec 31, 2020 | $269B |
| FY2021, ended Dec 31, 2021 | $292B |
| FY2022, ended Dec 31, 2022 | $322B |
| FY2023, ended Dec 31, 2023 | $358B |
| FY2024, ended Dec 31, 2024 | $373B |
| FY2025, ended Dec 31, 2025 | $402B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $415B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.32B | $7.92B |
| FY2017, ended Dec 31, 2017 | $6.62B | $6.09B |
| FY2018, ended Dec 31, 2018 | −$594M | $6.83B |
| FY2019, ended Dec 31, 2019 | $6.63B | $10.4B |
| FY2020, ended Dec 31, 2020 | $7.18B | $13.4B |
| FY2021, ended Dec 31, 2021 | $8.00B | $15.7B |
| FY2022, ended Dec 31, 2022 | $4.31B | $13.4B |
| FY2023, ended Dec 31, 2023 | $8.34B | $10.4B |
| FY2024, ended Dec 31, 2024 | $4.61B | $6.33B |
| FY2025, ended Dec 31, 2025 | $1.77B | $7.81B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.89B | $11.8B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.37B |
| FY2017, ended Dec 31, 2017 | $1.70B |
| FY2018, ended Dec 31, 2018 | $4.06B |
| FY2019, ended Dec 31, 2019 | $5.68B |
| FY2020, ended Dec 31, 2020 | $7.85B |
| FY2021, ended Dec 31, 2021 | $9.41B |
| FY2022, ended Dec 31, 2022 | $12.9B |
| FY2023, ended Dec 31, 2023 | $8.20B |
| FY2024, ended Dec 31, 2024 | $8.59B |
| FY2025, ended Dec 31, 2025 | $8.45B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $11.3B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.6B |
| FY2017, ended Dec 31, 2017 | $28.3B |
| FY2018, ended Dec 31, 2018 | $74.1B |
| FY2019, ended Dec 31, 2019 | $68.5B |
| FY2020, ended Dec 31, 2020 | $64.6B |
| FY2021, ended Dec 31, 2021 | $56.2B |
| FY2022, ended Dec 31, 2022 | $52.3B |
| FY2023, ended Dec 31, 2023 | $61.6B |
| FY2024, ended Dec 31, 2024 | $66.3B |
| FY2025, ended Dec 31, 2025 | $64.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $61.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 24.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.03B |
| FY2017, ended Dec 31, 2017 | 1.01B |
| FY2018, ended Dec 31, 2018 | 1.30B |
| FY2019, ended Dec 31, 2019 | 1.30B |
| FY2020, ended Dec 31, 2020 | 1.31B |
| FY2021, ended Dec 31, 2021 | 1.31B |
| FY2022, ended Dec 31, 2022 | 1.28B |
| FY2023, ended Dec 31, 2023 | 1.26B |
| FY2024, ended Dec 31, 2024 | 1.26B |
| FY2025, ended Dec 31, 2025 | 1.27B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.28B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.46B | $222M | — |
| FY2017, ended Dec 31, 2017 | $4.36B | $234M | — |
| FY2018, ended Dec 31, 2018 | $0 | $280M | $22.5B |
| FY2019, ended Dec 31, 2019 | $0 | $453M | — |
| FY2020, ended Dec 31, 2020 | $0 | $400M | — |
| FY2021, ended Dec 31, 2021 | $0 | $484M | — |
| FY2022, ended Dec 31, 2022 | $3.50B | $447M | — |
| FY2023, ended Dec 31, 2023 | $2.01B | $588M | — |
| FY2024, ended Dec 31, 2024 | $3.02B | $540M | — |
| FY2025, ended Dec 31, 2025 | $0 | $535M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $715M | — |
Valuation
At current price- Market Cap
- $117B
- P/E
- 23.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.3×
- Price / Book
- 1.5×
- EV / EBITDA
- 13.0×
Growth
Trailing 12 months- Revenue (TTM)
- $415B
- Revenue Growth YoY
- 7.4%
- Revenue CAGR 3Y
- 7.6%
- Revenue CAGR 5Y
- 8.4%
- EPS Growth YoY
- 5.6%
- Net Income Growth YoY
- 7.9%
Profitability
Trailing 12 months- Gross Margin
- 44.5%
- Operating Margin
- 2.0%
- Net Margin
- 1.2%
- FCF Margin
- 2.8%
- Return on Equity
- 6.2%
Earnings
Trailing 12 months- Net Income
- $4.89B
- EPS (diluted)
- $3.79
- EBITDA
- $12.8B
- Operating Income
- $8.29B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $11.3B
- Total Debt
- $61.4B
- Net Debt
- $50.1B
- Total Assets
- $254B
- Total Liabilities
- $174B
- Shareholders' Equity
- $79.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $14.8B
- Capital Expenditure
- $3.02B
- Free Cash Flow
- $11.8B
Dividends and risk
Last 12 months- Dividend Yield
- 2.9%
- Dividend / Share
- $2.66
- Beta (5Y)
- 0.60
Every ratio is calculated from the company’s reported figures.